WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES

Mark Identification

ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES

Click here to search for trademarks similar to ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES

Proof of use for ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES

We do not have any records of a proof of use for ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES at this moment.

Click here to add a proof of use for ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES

Possible trademark infringements of ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES

Basic Information about ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES

Serial Number
97693879
Filing Date
28 Nov 2022
Mark Drawing Code
3

Classifications

Declare the trademark use of ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES on the blockchain with WikiTrademarks.io.

First use of ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES anywhere
ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES was first used on 31 Dec 2023 for the primary classification of goods and services, international, 035 (Advertising and business)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
035
US Codes
100; 101; 102
First use of ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES anywhere
ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES was first used on 31 Dec 2023 for the primary classification of goods and services, international, 036 (Insurance and financial)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
036
US Codes
100; 101; 102
First use of ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES anywhere
ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES was first used on 31 Dec 2023 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
044
US Codes
100; 101

Who owns ELAHERE MIRVETUXIMAB SORAVTANSINE INJECTION 100 MG SUPPORT SERVICESION 100 MG SUPPORT SERVICES?

1. ImmunoGen, Inc. Waltham MA

2. ImmunoGen, Inc. Waltham MA

Correspondent

Nicole Kinsley, Esq. FOLEY HOAG LLP
155 SEAPORT BLVD.
BOSTON, MA 02210-2600
United States